Addressing Alopecia Areata
Join expert contributors for this podcast series highlighting approaches to alopecia areata (AA) treatment and management.
Unmet needs in the management of alopecia areata
Episode 1. “The most important things that I can do is acknowledge the experience and normalize that this is hard.” Dermatologist Brittany Craiglow and patient advocate Damien Hamber discuss unmet needs in AA management and their impact on patients.
Treatment choice, shared decision-making, and treatment planning
Episode 2. “[People with AA] want to talk to someone who not only understands the condition medically but the impact that it’s going to have on the individual, and present them with ways forward.” Patient advocate Damien Hamber and dermatologist Brittany Craiglow discuss the importance of treatment selection and planning, alongside active collaboration, in effective clinical management of AA.
Long-term management of alopecia areata with JAK inhibitors
Episode 3. “[JAK inhibitors] can be really life-changing for patients.” Dermatologist Leila Asfour discusses the nuances of Janus kinase (JAK) inhibitors in long-term AA management.
Alopecia areata pathophysiology
Episode 4. “We don’t understand that initial inciting event that causes alopecia areata. Patients come into the clinic fixated on the ‘why,’ which is still not well understood.” Dermatologist Brittany Craiglow discusses advances in our understanding of AA pathogenesis, including the role of the JAK–STAT pathway and potential treatment targets.
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, who has reviewed the content only for scientific accuracy. EPG Health received funding from the sponsor in order to help provide healthcare professionals with access to the highest quality medical and scientific information, education and associated relevant content.